CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion
Open Access
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (15) , 6269-6280
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31560320)
- Natural Science Foundation of Jiangxi Province (20142BAB215049)
This publication has 35 references indexed in Scilit:
- GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancersOncotarget, 2016
- Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancerOncotarget, 2015
- Regulation of GATA-binding Protein 2 Levels via Ubiquitin-dependent Degradation by Fbw7Journal of Biological Chemistry, 2015
- High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancerAnnals of Oncology, 2014
- Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, ChinaCancer Letters, 2014
- Pancreatic cancer in the spotlightThe Lancet Oncology, 2014
- Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancersNature Reviews Cancer, 2010
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7Cell Metabolism, 2005
- Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 ReceptorJournal of Biological Chemistry, 2001